Your session is about to expire
← Back to Search
Other
CP4071 for Sarcoma
Phase 2
Waitlist Available
Research Sponsored by Herbert Irving Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Metastatic or locally advanced
No CNS metastases
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is studying the side effects of CP4071 in treating patients with soft tissue sarcoma.
Who is the study for?
This trial is for adults over 18 with advanced or metastatic soft tissue sarcoma who have tried at least one therapy before. They should not have brain metastases, other recent cancers except certain skin cancers and treated stage I or II cancer, and must be in fairly good health. Pregnant or nursing individuals can't join, and participants need to use contraception.Check my eligibility
What is being tested?
The study is testing the effectiveness of a chemotherapy drug called CP4071 on patients with locally advanced or metastatic soft tissue sarcoma. It's a Phase II trial which means they're looking at how well it works and its safety after initial tests showed promise.See study design
What are the potential side effects?
While specific side effects of CP4071 are not listed here, common side effects from chemotherapy drugs like this may include fatigue, nausea, hair loss, increased risk of infection due to low blood cell counts, bleeding problems, kidney issues among others.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My cancer has spread to other parts of my body or is locally advanced.
Select...
My cancer has not spread to my brain.
Select...
My cancer is a type of soft tissue sarcoma confirmed by lab tests.
Select...
I am 18 years old or older.
Select...
I can take care of myself and am up and about more than 50% of my waking hours.
Select...
I have tried at least one treatment that didn't work for my condition.
Select...
My cancer can be measured and is outside the area previously treated with radiation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
Herbert Irving Comprehensive Cancer CenterLead Sponsor
34 Previous Clinical Trials
1,089 Total Patients Enrolled
4 Trials studying Sarcoma
52 Patients Enrolled for Sarcoma
National Cancer Institute (NCI)NIH
13,665 Previous Clinical Trials
40,925,854 Total Patients Enrolled
454 Trials studying Sarcoma
230,205 Patients Enrolled for Sarcoma
Robert N. Taub, MD, PhDStudy ChairHerbert Irving Comprehensive Cancer Center
6 Previous Clinical Trials
109 Total Patients Enrolled
4 Trials studying Sarcoma
52 Patients Enrolled for Sarcoma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had 3 or fewer chemotherapy treatments for my advanced cancer.I am not receiving any other chemotherapy treatments.My cancer has spread to other parts of my body or is locally advanced.I haven't had any cancer except for early-stage, cervical, or certain skin cancers in the last 5 years.My cancer has not spread to my brain.It has been over 4 weeks since my last surgery and I have recovered.My cancer is a type of soft tissue sarcoma confirmed by lab tests.I am 18 years old or older.I am not currently on hormonal therapy for cancer.It's been over 3 weeks since my last radiotherapy and I have recovered.I am not taking any heart medication similar to digoxin.I can take care of myself and am up and about more than 50% of my waking hours.I have had treatment to boost my immune system.I have tried at least one treatment that didn't work for my condition.My cancer can be measured and is outside the area previously treated with radiation.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has this medication obtained regulatory clearance from the FDA?
"Our team at Power assigned a rating of 2 to this intervention's safety, as phase 2 trials are typically associated with preliminary evidence on the treatment's security but no proof that it is effective."
Answered by AI
Are there still spots accessible for participants in this research?
"As per the information hosted on clinicaltrials.gov, this trial is not actively recruiting new participants; it was initially posted in October of 2000 and its most recent update came in January 2014. However, 443 other studies at present are seeking volunteers for their respective trials."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger